EvoqTM Technologies Achieves Breakthrough With Its Smartphone-Based System for Early Detection and Diagnosis of Diseases
LAS VEGAS--(BUSINESS WIRE)--Nov 11, 2021--
The newly released Evoq Smartphone-Based Electrophysiology System represents a revolutionary, cost-effective alternative to legacy desktop devices. The Evoq system is tailored to meet the needs of MD, OD, PhD, DVM, researchers, and technologists who are advancing the art and science of evoked response electrophysiology -- for vision, auditory, neurology, and physical therapy.
Our unique technology provides the ability to stimulate the body with various impulses such as light or sound, to measure the response in a quantifiable way to detect cellular / body responses. Delayed or reduced responses are often signatures of disease. While delivering diagnostics to a broader audience via smartphone, we nonetheless meet rigorous medical standards.
According to Daniel Lindgren, President of Evoq Technologies, “Our breakthrough, patented technology benefits patients, clinicians, and payers by offering a safer, cost-effective solution for detection and diagnosis while maintaining the standard-of-care on a smartphone-based platform.” He noted that the company plans to license its technology to pharmaceutical, medical device, and clinical research organizations as a novel means to capture patient data in the clinic, at the bedside, or even at home.
Lindgren will be attending the AAO meeting in New Orleans on November 12-13 th. Please call or email if you’d like to schedule a meeting to discuss licensing opportunities. (702) 747-4725 or firstname.lastname@example.org
Evoq Technologies is a privately held company based in Las Vegas, Nevada. It is comprised of an experienced team of scientists and engineers, clinicians, and seasoned business professionals with a track record of bringing new medical devices to market.
The Company has a long and distinguished lineage whose founders developed a leading line of products designed for the ophthalmic and visual science communities through their companies Xenotec, OcuScience, and now Evoq Technologies. Our mission is to meet the challenging requirements of our partners with the highest quality line of devices, accessories and support in the laboratory and clinic. Our focus is to improve the technology available to doctors and scientists to enable them to discover and develop new treatments for blindness and other neurological diseases.
View source version on businesswire.com:https://www.businesswire.com/news/home/20211111006194/en/
CONTACT: Evoq Technologies LLC
KEYWORD: UNITED STATES NORTH AMERICA LOUISIANA NEVADA
INDUSTRY KEYWORD: SCIENCE OTHER SCIENCE PHYSICAL THERAPY OPTICAL HEALTH MEDICAL DEVICES TECHNOLOGY MOBILE/WIRELESS
SOURCE: Evoq Technologies LLC
Copyright Business Wire 2021.
PUB: 11/11/2021 09:48 PM/DISC: 11/11/2021 09:48 PM